Gamida Cell is a cell and immune therapy visionary. The company’s world-class scientists have developed a broad platform technology to expand functional cells in culture to create unprecedented, life-saving cures for blood cancers such as leukemia and lymphoma and rare genetic diseases such as sickle cell disease.

Gamida Cell is well positioned to fill the un-met needs of several potentially multi-billion dollar markets by bringing allogeneic cell products to the clinic.

Gamida Cell has a broad worldwide patent portfolio and worldwide rights to all products.

The company has developed a cost effective and robust manufacturing process under GMP for each product and has in-house manufacturing capabilities.